FDA described as a “clown show” amid latest scandal; top drug regulator is out https://arstechni.ca #georgetidmarsh #pharmaceutical #vinayprasad #Health #drug #fda

The head of the #FDA's drug unit, #GeorgeTidmarsh, has reportedly been placed on #administrativeleave while an investigation is carried out into his personal #conduct.

pharmaphorum.com/news/cder-he...

FDA Drug Chief George Tidmarsh Resigns Amid Misconduct Allegations and $350 Million Lawsuit Over Market Manipulation Claims

👉 NewsLink7.com

#FDA #GeorgeTidmarsh #AuriniaPharmaceuticals #Lawsuit #Doctors #Pharmacy #PrescriptionMedication #Hospitals #Nurses #StockMarket #News #WorldNews #noticias

Tidmarsh to stand in for Prasad's role at CBER Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

The #FDA has moved swiftly to fill the void left by Vinay Prasad's resignation as director of the Center for Biologics Evaluation and Research (#CBER), appointing recent hire #GeorgeTidmarsh to the role.

pharmaphorum.com/news/tidmars...

The #FDA has a new director for the Center for Drug Evaluation and Research (#CDER), with biopharma industry executive #GeorgeTidmarsh named to the role.

pharmaphorum.com/news/fda-nam...

FDA to appoint George Tidmarsh as top drug regulator, Bloomberg News reports (Reuters) -U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the director of the Center for Drug Evaluation and Research, Bloomberg News reported on Monday, citing a person familiar with the decision. The Department of Health and Human Services, which oversees the FDA, did not immediately respond to a Reuters request for comment. Tidmarsh also did not immediately respond to email and LinkedIn requests for comment. AI computing powers are changing the stock market. Investing.com's ProPicks AI includes 6 winning stock portfolios chosen by our advanced AI. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. Which stock will be the next to soar?

Click Subscribe #FDA #GeorgeTidmarsh #DrugRegulation #Biotech #Healthcare